Viehbacher returns to lead Swiss billionaire’s $2B biotech fund

Alok Saboo FierceBiotech News

Google taps Boston brains for EU VC unit, Big Pharma VCs back Forendo, Swiss IPO halted

Nick Paul Taylor In this week's EuroBiotech Report, Google revealed further details of its $ 100 million (€79 million) European venture capital unit, which is hunting for ...

Prefer a Swiss tax rate? Basilea chief says he’s ready to parley

John Carroll Basilea CEO Ronald Scott offered that the next best step for the biotech may be to just sell the Basel-based company to a U.S.-based biopharma company interested in a quick ...

Swiss regulators deny Apricus ED drug

Eric Palmer Swiss authorities have thrown cold water on Apricus Biosciences' Vitaros, a topically-applied cream for erectile dysfunction. The product has been approved in Ireland, ...

Roche plows $105 million into training center to feed expansion of Swiss logistics plant

Eric Palmer Roche is building a $ 105 million training center at a key plant in the Swiss company's home country. FiercePharma News

Swiss biotech OncoEthix snags $19M round to back leukemia drug study

John Carroll Switzerland's OncoEthix has raised $ 19 million in venture cash to back its work on an early-stage cancer treatment, one of a new class of oncology drugs that's ...

How Much? ‘Evergreening’ And Drug Costs In One Swiss Town

esilverman For several years, the practice of evergreening has been a contentious topic. The term refers to patent extensions that are based on minor changes in a drug and ...

Amag pulls anemia drug batch after Swiss patient dies

Tracy Staton Amag Pharmaceuticals and partner Takeda have run into a snag in Switzerland. Japan-based Takeda is recalling a batch of Amag's anemia drug Feraheme, ...

Swiss billionaires create major biotech campus at former Serono site

John Carroll Two Swiss billionaires–Ernesto Bertarelli and Hansjorg Wyss–have joined forces to buy out the former Merck Serono facility in Geneva, with ambitious plans to ...

Novartis reverses course on Swiss OTC plant that was to be closed

Eric Palmer Novartis is doing a complete U-turn on an OTC plant in Switzerland that 18 months ago was going to get the old heave-ho along with the people who worked there. Now the ...

Swiss biotech raises $50.6M to further hearing-loss drugs

Emily Mullin Swiss biotech Auris Medical has raised $ 50.6 million in a Series C round of financing to advance its two major therapeutics for the treatment of inner ear disorders. The ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS